The APOLLO Trial
Now enrolling
Learn more about the trial evaluating the Intrepid™ transcatheter mitral valve replacement system — an investigational option for patients with moderate to severe symptomatic mitral regurgitation (MR), with or without mitral annular calcification (MAC), who meet eligibility criteria for the APOLLO Trial.
CAUTION: The Intrepid™ transcatheter mitral valve replacement system is an investigational device. Limited by federal (United States) law to investigational use. Exclusively for clinical investigations. Not approved by FDA and not for sale in the United States.
CAUTION: Investigational device. To be used by qualified investigators only. Exclusively for clinical investigations.
This page is intended for healthcare professionals interested in learning more about the APOLLO Trial.